This site is intended for healthcare professionals only
LoginRegister
Gauhati High Court orders Assam Govt to address issues with Reconstructive Surgery Facility for TransgendersGauhati High Court orders Assam Govt to address issues with Reconstructive Surgery Facility for...
Puducherry Govt Planning to Relax Eligibility Criteria for Medical Admission under 10 percent Quota for Govt School StudentsPuducherry Govt Planning to Relax Eligibility Criteria for Medical Admission under 10 percent Quota...
KNRUHS Bsc nursing counsellingBUFHS Releases Schedule for BSc Nursing 3rd Round Online Counseling
Railways Slapped Rs 9 L Fine After NEET Student Misses Exam due to Train DelayNCDRC holds Rs 7.5 Lakh Compensation Against Nursing Home for negligence, Sets Aside Suspension...
UP DGME Releases Round 2 NEET 2024 Counselling Schedule, Registrations Start From Sept 9UP DGME Releases Round 2 NEET 2024 Counselling Schedule, Registrations Start From Sept 9
MSD Pharma Gets Conditional SEC Approval to Begin Phase III Trial of Sacituzumab TirumotecanMSD Pharma gets CDSCO Panel nod to update prescribing information of Human Papillomavirus 9-valent...
IIT Dhanbad Recruitment: Medical Officer Post, Apply NowIIT Dhanbad Recruitment: Medical Officer Post, Apply Now
Health Ministry Reduces Clinical Trial Approval Time from 90 to 45 DaysMerck, EyeBio announce initiation of Phase 2b/3 clinical trial for Restoret for Diabetic Macular...
NEET PG 2025: Medical Education System in Crisis, Doctors Demand Answers from NBEMS & Health MinistryGMERS Associate professor acquitted in sexual harassment case due to lack of evidence
Eligibility Certificate Fee Should be at par with Indian Medical Graduates: TN FMG Wing Urges Health SecretaryEligibility Certificate Fee Should be at par with Indian Medical Graduates: TN FMG Wing Urges Health...
MCC NEET Counselling 2024 Round 2 choice filling to end on Sept 10, check scheduleMCC NEET Counselling 2024 Round 2 choice filling to end on Sept 10, check schedule
NPPA Finally Allows GSK to Discontinue Grisovin FPGSK announces positive results from phase III trial of Nucala in COPD
X